Prompt follow-up

Non-small cell lung cancer

The most common form of lung cancer. Subtype, stage, and biomarker test results shape which treatments are considered.

Preview — not yet published

This page is in editorial and medical review. Content below is a scaffold — treat it as a preview, not guidance.

In plain language

What non-small cell lung cancer is

A short definition first, before any detail.

The most common form of lung cancer. Subtype, stage, and biomarker test results shape which treatments are considered.

A plain-language analogy will appear here once editorial and medical review are complete.

Also known as: NSCLC, lung cancer, non-small cell lung cancer.

What patients usually want to know first

Urgency and next steps

Orientation before detail — so you know where you stand.

Urgency

Prompt follow-up

Don't wait long for next steps — book a follow-up with your doctor soon.

Symptoms that matter

Common signs, and red flags

Red-flag symptoms are the ones that need same-day attention.

Common symptoms

A reviewed list of common symptoms will appear here once editorial and medical review are complete.

Red-flag symptoms

If you have any of these, contact your doctor — or, for emergencies, call your local emergency number.

A reviewed red-flag list will appear here once editorial and medical review are complete.

What happens after diagnosis

Likely tests and referrals

The common next steps, in roughly the order they usually come.

A reviewed list of likely tests and referrals will appear here once editorial and medical review are complete.

Questions to ask your doctor

Practical prompts for your next visit

Not a script — a starting point. Bring the ones that matter to you.

  • Which subtype do I have (adenocarcinoma, squamous, or other)?

  • What stage is it, and has it spread outside the lung?

  • Has my tumor been tested for biomarkers like EGFR, ALK, or PD-L1?

    Biomarker results open up targeted therapies and immunotherapies for some patients.

  • Am I a candidate for surgery, radiation, targeted therapy, or immunotherapy?

  • Are there clinical trials for my subtype or biomarker profile?

Treatment pathways

Common routes — not personalized advice

Your care team decides what's right for you based on type, stage, and overall health.

A reviewed summary of treatment pathways will appear here once editorial and medical review are complete.

Types, stages, or subconditions

Why the specific type can matter

Different types or stages can have very different treatment options and outlooks.

A reviewed overview of types or stages will appear here once editorial and medical review are complete.

Research and clinical trials

When research may be worth considering

Research isn't the first step for everyone — it's an option to know about.

Clinical trials can offer access to new treatments, extra monitoring, or another option when standard treatments aren’t a fit. Whether a trial is worth considering depends on your specific situation — and on timing.

Keep reading

More on this condition

Review, sources, and disclaimer

How this page was reviewed

Medical review

Pending medical review. This page will list the reviewing clinician and review date before publication.

Sources

Sources will be listed here before publication. We prefer guideline-level and patient-trusted references.

This page is educational, not medical advice. Talk with your care team about decisions that apply to you. If something feels urgent, contact your doctor — or, for emergencies, call your local emergency number.